지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Drug utilization review (DUR) system has been defined as “structured, ongoing initiatives that interpret patterns of drug use in relation to predetermined criteria, and attempt to prevent or minimize inappropriate prescribing.” This paper introduces the concept, purpose, and effective application of DUR in Korea. DUR can be classified as retrospective DUR, prospective DUR, and concurrent DUR based on the time direction of applying DUR. DUR can also be classified as quantitative DUR defined by retrospective DUR using databases including previously prescribed medicines, and qualitative DUR defined by DUR reflecting patient’s clinical condition. We described the history of developing DUR in the United States and the Europe. Finally current status of DUR in Korea is described and the strategy of future settlement of DUR system in Korea is suggested.
목차
등록된 정보가 없습니다.
참고문헌 (11)
참고문헌 신청
Erwin WG / 1991 / The definition of drug utilization review: statement of issues / Clin Pharmacol Ther 50:596~599
Park JY / 2010 / DUR progress in the implementation and ways to expand nationwide / HIRA Policy Trend 4:23~28
Park BJ / 2008 / Drug utilization review / J Pharmacoepidemiol Risk Manag 1:13~19
Park BJ / 1999 / Background and current status of drug utilization review in the developed countries / Korean J Clin Pharmacol Ther 7:3~16
Hennessy S / 2005 / Drug utilization review in Pharmacoepidemiology. 4th ed / John Wiley :833~841
Park JY / 2010 / DUR progress in the implementation and ways to expand nationwide / HIRA Policy Trend 4:23~28
Park BJ / 2008 / Drug utilization review / J Pharmacoepidemiol Risk Manag 1:13~19
Park BJ / 1999 / Background and current status of drug utilization review in the developed countries / Korean J Clin Pharmacol Ther 7:3~16
Hennessy S / 2005 / Drug utilization review in Pharmacoepidemiology. 4th ed / John Wiley :833~841
이 논문의 저자 정보
최근 본 자료
댓글(0)
0